A vs DMAC
Agilent Technologies Inc (A) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
DMAC does not have a complete income-statement cache yet.
A currently screens at market cap $33.70B and trailing P/E 29.2. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the A and DMAC stock pages for the full models.
Not investment advice.